Russell Z. Szmulewitz to Prednisone
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Prednisone.
Connection Strength
0.490
-
Phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration-resistant prostate cancer. Prostate. 2019 11; 79(15):1752-1761.
Score: 0.169
-
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol. 2018 05 10; 36(14):1389-1395.
Score: 0.152
-
Corticosteroids and prostate cancer: friend or foe? Eur Urol. 2015 May; 67(5):874-5.
Score: 0.119
-
A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in Combination with Docetaxel plus Prednisone in Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1531-1539.
Score: 0.050